An internalizing antibody targeting of cell surface GRP94 effectively suppresses tumor angiogenesis of colorectal cancer
Colorectal cancer (CRC) is one of the life-threatening malignancies worldwide. Thus, novel potential therapeutic targets and therapeutics for the treatment of CRC need to be identified to improve the clinical outcomes of patients with CRC. In this study, we found that glucose-regulated protein 94 (G...
Main Authors: | Yea Bin Cho, Ji Woong Kim, Kyun Heo, Hyun Jung Kim, Sumi Yun, Hye Seung Lee, Ha Gyeong Shin, Hyunbo Shim, Hanjin Yu, Yun-Hee Kim, Sukmook Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-06-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222004401 |
Similar Items
-
Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth
by: Mee Hyun Jeoung, et al.
Published: (2019-11-01) -
Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy
by: Ji Woong Kim, et al.
Published: (2021-03-01) -
Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases
by: Sumi Yun, et al.
Published: (2021-06-01) -
Co-downregulation of GRP78 and GRP94 induces apoptosis and inhibits migration in prostate cancer cells
by: Lu Tong, et al.
Published: (2019-07-01) -
Structural and Functional Analysis of GRP94 in the Closed State Reveals an Essential Role for the Pre-N Domain and a Potential Client-Binding Site
by: John D. Huck, et al.
Published: (2017-09-01)